Evaluation of repeated clinical dose of rocuronium after reversal of neuromuscular block by sugammadex within a short time in re-surgical patients.
Not Applicable
- Conditions
- patients who required re-surgery within a short time after using sugammadex.
- Registration Number
- JPRN-UMIN000007647
- Lead Sponsor
- Asahikawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
patients with full stomach or with difficult airway.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time from administration of second Rocuronium to maximum depression of T1 height at the re-surgery.
- Secondary Outcome Measures
Name Time Method